KZR vs XLP
Kezar Life Sciences Inc (KZR) versus XLP (XLP) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
XLP (XLP) common stock.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
XLP does not have a complete income-statement cache yet.
KZR currently screens at market cap $53.9M. XLP currently screens at market cap $0.
Not investment advice. Open the KZR and XLP stock pages for the full models.
Not investment advice.